Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_assertion type Assertion NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_head.
- NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_assertion wasGeneratedBy ECO_0000203 NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_provenance.
- NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_assertion wasDerivedFrom befree-20140225 NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_provenance.
- NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_assertion SIO_000772 10318905 NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_provenance.
- NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_assertion evidence source_evidence_literature NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_provenance.
- NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_assertion description "[Using AG879, a HER2/Neu inhibitor, and PD98059, a MAP kinase inhibitor, as well as MAP kinase phosphatase-1 (MPK-1), in the transfection assay, we found that HER2/Neu could induce prostate-specific antigen (PSA), a marker for the progression of prostate cancer, through the MAP kinase pathway at a low androgen level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462818.RA8t6vMTp3NArcq_A5KmOY94xpQxGlYM3qNeFiakiPp1c130_provenance.